Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vofopitant dihydrochloride (GR 205171A) is an orally available, selective tachykinin NK1 receptor antagonist that inhibits [3H]SP binding to NK1 with pKi values of 9.5 and 10.6, respectively. It is a potential compound for the treatment of pathological vomiting.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $100 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $396 | In Stock | |
25 mg | $749 | In Stock | |
50 mg | $1,120 | In Stock | |
100 mg | $1,530 | In Stock | |
500 mg | $2,970 | In Stock | |
1 mL x 10 mM (in DMSO) | $275 | In Stock |
Description | Vofopitant dihydrochloride (GR 205171A) is an orally available, selective tachykinin NK1 receptor antagonist that inhibits [3H]SP binding to NK1 with pKi values of 9.5 and 10.6, respectively. It is a potential compound for the treatment of pathological vomiting. |
Targets&IC50 | NK1 (rat):9.5 (pKi), NK1 (human):10.6 (pKi) |
Alias | Vofopitant 2HCl, GR 205171A |
Molecular Weight | 505.36 |
Formula | C21H25Cl2F3N6O |
Cas No. | 168266-51-1 |
Smiles | Cl.Cl.COc1ccc(cc1CN[C@H]1CCCN[C@H]1c1ccccc1)-n1nnnc1C(F)(F)F |
Relative Density. | no data available |
Storage | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: 20 mg/mL (39.58 mM), Sonication is recommended. DMSO: 20 mg/mL (39.58 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.